UK markets close in 1 hour 38 minutes

Trinity Biotech plc (TRIB)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.8100+0.0600 (+3.43%)
As of 09:30AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 13.37M
Enterprise value 64.54M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.06
Price/book (mrq)5.11
Enterprise value/revenue 1.14
Enterprise value/EBITDA -2.68

Trading information

Stock price history

Beta (5Y monthly) 1.23
52-week change 3-65.69%
S&P500 52-week change 323.57%
52-week high 35.5000
52-week low 31.7500
50-day moving average 32.0472
200-day moving average 32.7490

Share statistics

Avg vol (3-month) 317.96k
Avg vol (10-day) 39.85k
Shares outstanding 57.64M
Implied shares outstanding 67.64M
Float 869.35M
% held by insiders 123.67%
% held by institutions 131.63%
Shares short (15 Apr 2024) 41.86k
Short ratio (15 Apr 2024) 40.1
Short % of float (15 Apr 2024) 40.04%
Short % of shares outstanding (15 Apr 2024) 40.02%
Shares short (prior month 15 Mar 2024) 44.3k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 41.19
Payout ratio 40.00%
Dividend date 301 Jul 2015
Ex-dividend date 405 Jun 2015
Last split factor 21:5
Last split date 323 Feb 2024

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -42.26%
Operating margin (ttm)-25.98%

Management effectiveness

Return on assets (ttm)-13.15%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)56.83M
Revenue per share (ttm)7.42
Quarterly revenue growth (yoy)-25.60%
Gross profit (ttm)N/A
EBITDA -14.16M
Net income avi to common (ttm)-36.87M
Diluted EPS (ttm)-19.2600
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)3.69M
Total cash per share (mrq)0.02
Total debt (mrq)54.86M
Total debt/equity (mrq)N/A
Current ratio (mrq)2.60
Book value per share (mrq)-3.12

Cash flow statement

Operating cash flow (ttm)-11.56M
Levered free cash flow (ttm)-11.02M